EQUITY

9 Months Ended

Apr. 30, 2023

EQUITY

EQUITY

NOTE 7 - EQUITY

Authorized Preferred Stock

The Company has authorized 10,000,000 shares of preferred stock at par value of $0.001 per share.

Series A Preferred stock

The Company has designated 100,000 shares of preferred stock at par value of $0.001 per share.

As of April 30, 2023, and July 31, 2022, the Company had 100,000 shares of Series A preferred stock issued and outstanding.

Authorized Common Stock

The Company has authorized 300,000,000 shares of common stock at par value of $0.001 per share. Each share of common stock entitles the holder to one vote on any matter on which action of the stockholders of the corporation is sought.

During the nine months ended April 30, 2023, the Company issued 700 shares of common stock for an adjustment of reverse stock split in June 2022.

During the nine months ended April 30, 2023, a shareholder returned 10,000 shares of common stock and the Company canceled 10,000 shares of common stock.

As of April 30, 2023, and July 31, 2022, the Company had 586,686 and 595,986 shares of common stock issued and outstanding, respectively.

As of April 30, 2023, and July 31, 2022, the Company had no options and warrants outstanding.